From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
CAS Number
PubChem CID
Chemical and physical data
Formula C9H13N3
Molar mass 163.219
3D model (JSmol)
 NoYesY (what is this?)  (verify)

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2][3]


  1. ^ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current Opinion in Investigational Drugs. 5 (1): 76–81. PMID 14983978. 
  2. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem. 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372. 
  3. ^ Xu, Naxing; Kim, Grace E.; Gregg, Hope; Wagdy, Azza; Swaine, Brendan A.; Chang, Min S.; El-Shourbagy, Tawakol A. (September 2004). "Automated 96-well liquid–liquid back extraction liquid chromatography–tandem mass spectrometry method for the determination of ABT-202 in human plasma". Journal of Pharmaceutical and Biomedical Analysis. 36 (1): 189–195. doi:10.1016/j.jpba.2004.05.013.